About this trial
The aim is to use AI to assist surgeons in analyzing CLSM tissue slide images obtained during BCC surgeries with the aim to integrate it in real time. We plan to use AI to analyze CLSM images of BCCs and distinguish between tumor tissue, inflammatory tissue, and non-tumor/non-inflammatory tissue. This approach would provide surgeons with real-time feedback and automated image analysis, leading to a more targeted and efficient approach to tissue analysis. By improving the accuracy and speed of tissue analysis, our proposal could ultimately improve operative patient outcomes and benefit healthcare professionals.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with Basal Cell Carcinoma
Disqualifiers
Patient unable to consent
Trial population
Patients with Basal Cell Carcinoma undergoing biopsy or surgery
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Ex vivo confocal microscopy
Procedure/SurgeryThe aim is to use AI to assist surgeons in analyzing CLSM tissue slide images obtained during BCC surgeries with the aim to integrate it in real time. We plan to use AI to analyze CLSM images of BCCs and distinguish between tumor tissue, inflammatory tissue, and non-tumor/non-inflammatory tissue. This approach would provide surgeons with real-time feedback and automated image analysis, leading to a more targeted and efficient approach to tissue analysis. By improving the accuracy and speed of tissue analysis, our proposal could ultimately improve operative patient outcomes and benefit healthcare professionals.
Treatment groups
Trial outcomes
Primary outcomes
Ex vivo confocal laser scanning microscopy
Reaching the planned number of 1000 patients
Sponsors and contacts
Click on the lead sponsor to view all of their trials.